Rare diseases
Investigational molecules
Locations
804-322 11 Avenue South West, T2R 0C5
Oncolytics Biotech Inc. supports clinical research in advanced and metastatic gastrointestinal tumors, with a focus on cancers arising in the digestive tract.
The sponsor’s research activity is centered on patients with difficult-to-treat gastrointestinal malignancies across multiple collaborating sites in Canada.
Oncolytics Biotech Inc. runs clinical trials in conditions such as Anal squamous cell carcinoma, Anal cancer, Colorectal cancer metastatic, Pancreatic carcinoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
